Breast cancer with bone metastasis: molecular insights and clinical management

K Venetis, R Piciotti, E Sajjadi, M Invernizzi, S Morganti… - Cells, 2021 - mdpi.com
Despite the remarkable advances in the diagnosis and treatment of breast cancer patients,
the presence or development of metastasis remains an incurable condition. Bone is one of …

Clinical relevancy of circulating tumor cells in breast cancer: epithelial or mesenchymal characteristics, single cells or clusters?

I Fridrichova, L Kalinkova, S Ciernikova - International Journal of …, 2022 - mdpi.com
Metastatic breast cancer (MBC) is typically an incurable disease with high mortality rates;
thus, early identification of metastatic features and disease recurrence through precise …

Gold-nanoparticle hybrid nanostructures for multimodal cancer therapy

AA Ali, WH Abuwatfa, MH Al-Sayah, GA Husseini - Nanomaterials, 2022 - mdpi.com
With the urgent need for bio-nanomaterials to improve the currently available cancer
treatments, gold nanoparticle (GNP) hybrid nanostructures are rapidly rising as promising …

The interleukin-17 family of cytokines in breast cancer

JAS Fabre, J Giustiniani, C Garbar… - International journal of …, 2018 - mdpi.com
Breast cancer (BC) is the most common cancer in women worldwide and remains a major
cause of mortality with an expected 137,000 death this year in Europe. Standard …

The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target

T Shibabaw, B Teferi, B Ayelign - Frontiers in Immunology, 2023 - frontiersin.org
Metastatic breast cancer is one of the most common and well-known causes of death for
women worldwide. The inflammatory tumor cell and other cancer hallmarks dictate the …

[HTML][HTML] Addressing genetic tumor heterogeneity, post-therapy metastatic spread, cancer repopulation, and development of acquired tumor cell resistance

DC Harrer, F Lüke, T Pukrop, L Ghibelli, A Reichle… - Cancers, 2023 - mdpi.com
Simple Summary The present review summarizes and interprets uniform therapy schemes
for rescuing relapsed or refractory (r/r) neoplasias of quite different histologic origins …

Oligometastatic breast cancer: Are we there yet?

M AlSendi, D O'Reilly, YH Zeidan… - International journal of …, 2021 - Wiley Online Library
Patients with metastatic breast cancer are usually considered incurable. Recent advances
have resulted in significant improvements in survival for patients with metastatic breast …

Real-world tumor response of palbociclib plus letrozole versus letrozole for metastatic breast cancer in US clinical practice

A Brufsky, X Liu, B Li, L McRoy, RM Layman - Targeted oncology, 2021 - Springer
Background Limited information exists regarding tumor response to palbociclib plus an
aromatase inhibitor (AI) versus AI alone in real-world practice. Objective To evaluate the real …

Exercise reduces intramuscular stress and counteracts muscle weakness in mice with breast cancer

T Mader, T Chaillou, ES Alves, B Jude… - Journal of Cachexia …, 2022 - Wiley Online Library
Background Patients with breast cancer exhibit muscle weakness, which is associated with
increased mortality risk and reduced quality of life. Muscle weakness is experienced even in …

Stereotactic body radiation therapy in patients with oligometastatic disease: Clinical state of the art and perspectives

R Kinj, E Muggeo, L Schiappacasse, J Bourhis… - Cancers, 2022 - mdpi.com
Simple Summary Stereotactic radiation therapy (SBRT) is a type of radiation therapy in
which a small number of high doses of radiation are delivered to a target volume using …